AquaBounty Technologies, Inc. (AQB) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

26/100

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

25

Expensive

Momentum

33

Weakening

Sentiment

42

Mixed

Risk resilience

22

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.

Industry: Agricultural Farm Products
Sector: Consumer Defensive
Headquarters: US
CEO: David A. Frank
Listed since: Jan 11, 2017
Employees: 3

Market position

Day range

Current $1.31

$1.27$1.34

52-week range

Current $1.31

$0.735$2.95

Open: $1.30
Previous close: $1.31
Volume: 46.45K; 0.13× average
Average volume: 359.86K; Average daily volume
Market cap: 6.74M USD
Beta: 1.4; Market reference 1
50-day average: $1.0724; +22.16% above average
200-day average: $0.9788; +33.84% above average

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

3.14M USD+167.01%

Operating income

−4.02M USD+58.26%

Net income

−18.49M USD+87.61%

Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	—	—	3.14M USD	1.17M USD
Cost of goods sold	—	—	15.28M USD	13.63M USD	10.79M USD
Gross profit	—	—	−15.28M USD	−10.49M USD	−9.61M USD
Research and development	—	203.3K USD	506.24K USD	903.98K USD	2.15M USD
Selling, general, and administrative	4.02M USD	9.23M USD	13.17M USD	10.93M USD	10.36M USD
Operating expenses	4.02M USD	9.63M USD	−1.61M USD	11.83M USD	12.51M USD
Interest expense	206.05K USD	2.29M USD	303.97K USD	291.18K USD	316.44K USD
Depreciation and amortization	—	904.14K USD	2.16M USD	2.02M USD	1.79M USD
Operating income	−4.02M USD	−9.63M USD	−13.67M USD	−22.32M USD	−22.12M USD
Net income	−18.49M USD	−149.19M USD	−27.56M USD	−22.16M USD	−22.32M USD